Abstract
Time-kill assay and Etest testing for synergy of meropenem (MER) (1x MIC) plus polymyxin B (1/4, 1/2, and 1x MIC) were performed against 8 genetically unique MER-resistant clinical Acinetobacter baumannii isolates. Time-kill assay demonstrated synergy for all isolates, whereas Etest showed synergy in 5 isolates and indifference in 3.
MeSH terms
-
Acinetobacter Infections / microbiology
-
Acinetobacter baumannii / drug effects
-
Acinetobacter baumannii / genetics*
-
Anti-Bacterial Agents / pharmacology*
-
Clinical Laboratory Techniques
-
Colony Count, Microbial / methods
-
Drug Resistance, Bacterial / genetics*
-
Drug Resistance, Bacterial / physiology
-
Drug Synergism
-
Humans
-
Meropenem
-
Microbial Sensitivity Tests
-
Polymyxin B / pharmacology*
-
Thienamycins / pharmacology*
Substances
-
Anti-Bacterial Agents
-
Thienamycins
-
Meropenem
-
Polymyxin B